Adamas Reports Recent Achievements and First Quarter 2017 Financial Results
May 09, 2017 20:04 pm UTC| Business
EMERYVILLE, Calif., May 09, 2017 -- Adamas Pharmaceuticals, Inc. (Nasdaq:ADMS) today reported recent achievements and financial results for the first quarter ended March 31, 2017. “In the first quarter, we continued...
Vital Therapies Announces First Quarter 2017 Financial Results
May 09, 2017 20:04 pm UTC| Business
SAN DIEGO, May 09, 2017 -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver failure, today announced results for the...
Vital Therapies Announces First Quarter 2017 Financial Results
May 09, 2017 20:04 pm UTC| Business
SAN DIEGO, May 09, 2017 -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver failure, today announced results for the...
Vital Therapies Announces First Quarter 2017 Financial Results
May 09, 2017 20:04 pm UTC| Business
SAN DIEGO, May 09, 2017 -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver failure, today announced results for the...
Vital Therapies Announces First Quarter 2017 Financial Results
May 09, 2017 20:04 pm UTC| Business
SAN DIEGO, May 09, 2017 -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver failure, today announced results for the...
Fossil Group, Inc. Reports First Quarter Fiscal Year 2017 Results
May 09, 2017 20:03 pm UTC| Business
First Quarter Net Sales of $582 Million; Diluted EPS (Loss) of $(1.00), Including a Restructuring Charge of $0.35 per Diluted Share Provides Second Quarter and Updates Annual Fiscal 2017 GAAP Guidance RICHARDSON,...
Fossil Group, Inc. Reports First Quarter Fiscal Year 2017 Results
May 09, 2017 20:03 pm UTC| Business
First Quarter Net Sales of $582 Million; Diluted EPS (Loss) of $(1.00), Including a Restructuring Charge of $0.35 per Diluted Share Provides Second Quarter and Updates Annual Fiscal 2017 GAAP Guidance RICHARDSON,...